Neoplasms, Radiation-InducedInduction ChemotherapyAntineoplastic Combined Chemotherapy ProtocolsDose-Response Relationship, RadiationRadiation DosageCarcinogensUltraviolet RaysCombined Modality TherapyCisplatinChemotherapy, AdjuvantRemission InductionSkin NeoplasmsTreatment OutcomeDisease-Free SurvivalSurvival AnalysisAntineoplastic AgentsSurvival RateLung NeoplasmsCyclophosphamideNeoplasm StagingHead and Neck NeoplasmsEtoposideNeoadjuvant TherapyCarcinoma, Squamous CellCytarabinePrognosisDoxorubicinTaxoidsPaclitaxelLeukemia, Myeloid, AcuteFluorouracilCarboplatinDaunorubicinDrug Administration ScheduleBreast NeoplasmsCarcinoma, Non-Small-Cell LungRadiotherapy, AdjuvantIfosfamideVincristineEnzyme InductionNeoplasm Recurrence, LocalRadiotherapyChemoradiotherapyFollow-Up StudiesMethotrexatePrecursor Cell Lymphoblastic Leukemia-LymphomaVinblastineDeoxycytidineNeoplasm MetastasisRadiotherapy DosageLaryngectomyHypopharyngeal NeoplasmsIdarubicinKaplan-Meier EstimateBleomycinProspective StudiesLeukemia, MyeloidDrug Resistance, NeoplasmTransplantation, AutologousAntimetabolites, AntineoplasticSalvage TherapyTime FactorsNasopharyngeal NeoplasmsNeutropeniaOvarian NeoplasmsTesticular NeoplasmsDose-Response Relationship, DrugNeoplasmsEarly Detection of CancerMelphalanGranulocyte Colony-Stimulating FactorOrganoplatinum CompoundsRetrospective StudiesAdenocarcinomaDisease ProgressionMitoxantroneOrgan Sparing TreatmentsAsparaginaseAntineoplastic Agents, PhytogenicLaryngeal NeoplasmsDose FractionationMucositisCarcinomaStomach NeoplasmsClinical Trials as TopicCranial IrradiationTumor Markers, BiologicalAnthracyclinesVindesineRadiotherapy, High-EnergyLevoleucovorinBone NeoplasmsHematopoietic Stem Cell TransplantationGlossectomyCell Line, TumorOropharyngeal NeoplasmsColonic NeoplasmsRecurrenceNeoplasms, Germ Cell and EmbryonalMultivariate Analysis